Back
Vanguard S&P Mid-Cap 400 Value Index Fund ETF Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Buy
69
IVOV
Vanguard S&P Mid-Cap 400 Value Index Fund ETF
Last Price:
$102.70
Seasonality Move:
4.79%
Buy
59
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$779.28
Seasonality Move:
12.13%
Buy
69
Vanguard S&P Mid-Cap 400 Value Index Fund ETF (IVOV)
is a Buy
Is Vanguard S&P Mid-Cap 400 Value Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard S&P Mid-Cap 400 Value Index Fund ETF [IVOV] share price is $102.87. The Score for IVOV is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
IVOV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $779.36. The Score for REGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IVOV Stock Price Chart
What is Vanguard S&P Mid-Cap 400 Value Index Fund ETF's stock price today?
-
The Vanguard S&P Mid-Cap 400 Value Index Fund ETF share price today is $102.87The current trend is moderately bearish and IVOV is experiencing slight buying pressure.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $779.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
IVOV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.95 | Buy |
| Relative Strength Index (14 RSI): | 53.07 | Buy |
| Chaikin Money Flow: | 7694 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (99.25 - 104.31) | Buy |
| Bollinger Bands (100): | (98.08 - 102.46) | Buy |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 170.19 | Buy |
| Relative Strength Index (14 RSI): | 66.65 | Buy |
| Chaikin Money Flow: | 443253 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (715.94 - 768.12) | Buy |
| Bollinger Bands (100): | (553.77 - 702.07) | Buy |
IVOV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 103.93 | Sell |
| 20-day SMA: | 102.9 | Sell |
| 50-day SMA: | 100.85 | Buy |
| 200-day SMA: | 96.39 | Buy |
| 8-day EMA: | 103.51 | Sell |
| 20-day EMA: | 102.72 | Buy |
| 50-day EMA: | 101.41 | Buy |
| 200-day EMA: | 98.15 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 754.11 | Buy |
| 20-day SMA: | 746.27 | Buy |
| 50-day SMA: | 682.32 | Buy |
| 200-day SMA: | 601.27 | Buy |
| 8-day EMA: | 484.97 | Buy |
| 20-day EMA: | 251.66 | Buy |
| 50-day EMA: | 112.68 | Buy |
| 200-day EMA: | 29.86 | Buy |
Vanguard S&P Mid-Cap 400 Value Index Fund ETF Earnings Growth & IVOV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.
Vanguard S&P Mid-Cap 400 Value Index Fund ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||